CM336 Injection
CM336-IIS-PP01
Phase 2 mab active
Quick answer
CM336 Injection for Autoimmune Bullous Disease is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Autoimmune Bullous Disease
- Phase
- Phase 2
- Modality
- mab
- Status
- active